Get startedLog in
    Picture of Matinas BioPharma Holdings logo

    MTNB — Matinas BioPharma Holdings News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapNeutral
    All News

    Brief: Matinas Biopharma Holdings Inc Awarded Up To $3.75 Million From Cystic Fibrosis Foundation

    Picture of Matinas BioPharma Holdings logoMatinas BioPharma Holdings
    20/11/2020 12:39
    Nov 20 (Reuters) - Matinas BioPharma Holdings Inc  MTNB.A :
    * MATINAS BIOPHARMA HOLDINGS INC - AWARDED UP TO $3.75
MILLION
FROM CYSTIC FIBROSIS FOUNDATION (CFF)
    * MATINAS BIOPHARMA HOLDINGS INC - AWARD WILL SUPPORT
PRECLINICAL
DEVELOPMENT OF MAT2501
    * MATINAS BIOPHARMA HOLDINGS INC - AWARD WILL SUPPORT
PRECLINICAL
IN VITRO & IN VIVO STUDIES, ALONG TOXICOLOGY STUDIES TO PROGRESS
MAT2501 INTO PHASE 2

Source text for Eikon:  ID:nGNX844jZr 
Further company coverage:  MTNB.A 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Matinas BioPharma Holdings

    See all news